These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16614461)

  • 41. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes.
    Cabré A; Lázaro I; Girona J; Manzanares J; Marimón F; Plana N; Heras M; Masana L
    J Intern Med; 2007 Oct; 262(4):496-503. PubMed ID: 17875187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complications impaired endothelial progenitor cell function in Type 2 diabetic patients with or without critical leg ischaemia: implication for impaired neovascularization in diabetes.
    Chen MC; Sheu JJ; Wang PW; Chen CY; Kuo MC; Hsieh CJ; Chen JF; Chang HW
    Diabet Med; 2009 Feb; 26(2):134-41. PubMed ID: 19236615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy.
    Makino H; Okada S; Nagumo A; Sugisawa T; Miyamoto Y; Kishimoto I; Kikuchi-Taura A; Soma T; Taguchi A; Yoshimasa Y
    Diabet Med; 2009 Feb; 26(2):171-3. PubMed ID: 19236621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal perfusion and disease progression.
    Sensirivatana R; Kingwatanakul P; Futrakul P
    J Med Assoc Thai; 1999 May; 82(5):496-505. PubMed ID: 10443100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glomerular endothelial dysfunction and hemodynamic maladjustment in vesicoureteric reflux.
    Futrakul N; Laohaphaibul A; Futrakul P
    Ren Fail; 2003 May; 25(3):479-83. PubMed ID: 12803512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Magistral and intrarenal blood flow in type 2 diabetes mellitus patients with kidney lesions].
    Georgian Med News; 2014 Sep; (234):56-60. PubMed ID: 25341239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.
    Bjornstad P; Lovshin JA; Lytvyn Y; Boulet G; Lovblom LE; Alhuzaim ON; Farooqi MA; Lai V; Tse J; Cham L; Orszag A; Scarr D; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Perkins BA; Cherney DZI
    Diabetes Care; 2018 Apr; 41(4):831-839. PubMed ID: 29437821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication.
    Futrakul N; Tosukhowong P; Valyapongpichit Y; Tipprukmas N; Futrakul P; Patumraj S
    Ren Fail; 2002 Jul; 24(4):433-45. PubMed ID: 12212823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal microvascular disease predicts renal function in diabetes.
    Futrakul N; Futrakul P
    Ren Fail; 2012; 34(1):126-9. PubMed ID: 22010784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Renal hemodynamics in patients with diabetes mellitus].
    Mamedov R; Blagosklonnaia IaV; Emanuel' VL
    Vrach Delo; 1981 Nov; (11):43-5. PubMed ID: 7342440
    [No Abstract]   [Full Text] [Related]  

  • 54. [Preclinical diagnostics and correction of the disturbed renal blood flow in the children presenting with diabetic nephropathy].
    Aver'ianov AP; Tkacheva EN; Bolotova NV; Filina NIu; Ivanova IuV; Nikolaeva NV; Tikhonova LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2011; (5):25-9. PubMed ID: 22165142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatments of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chronically severe glomerulonephritides.
    Futrakul N; Tohsukhowong P; Patumraj S; Siriviriyakuk P; Tipprukmas N; Futrakul P
    Ren Fail; 2003 Sep; 25(5):839-44. PubMed ID: 14575291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of serum and urinary transforming growth factor-beta levels as markers of diabetic nephropathy.
    Mogyorósi A; Kapoor A; Isono M; Kapoor S; Sharma K; Ziyadeh FN
    Nephron; 2000 Oct; 86(2):234-5. PubMed ID: 11015017
    [No Abstract]   [Full Text] [Related]  

  • 57. Glomerular endothelial dysfunction in chronic kidney disease.
    Futrakul N; Panichakul T; Sirisinha S; Futrakul P; Siriviriyakul P
    Ren Fail; 2004 May; 26(3):259-64. PubMed ID: 15354975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pilot trial to examine the association between circulating endothelial cell levels and vascular injury in patients with diabetes and chronic kidney disease.
    Shirazian S; Grant C; Rambhujun V; Sharma R; Patel R; Islam S; Mattana J
    F1000Res; 2016; 5():292. PubMed ID: 27303625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urgent call for reconsideration of chronic kidney disease.
    Futrakul N; Futrakul P
    World J Nephrol; 2012 Dec; 1(6):155-9. PubMed ID: 24175254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular response to vasodilator treatment in microalbuminuric diabetic kidney disease.
    Futrakul N; Futrakul P
    World J Nephrol; 2013 Nov; 2(4):125-8. PubMed ID: 24255895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.